首页|Nanjing University of Chinese Medicine Reports Findings in Hematoma [Application of Robotic Stereotactic Assistance (ROSA) for spontaneous intracereb ral hematoma aspiration and thrombolytic catheter placement]
Nanjing University of Chinese Medicine Reports Findings in Hematoma [Application of Robotic Stereotactic Assistance (ROSA) for spontaneous intracereb ral hematoma aspiration and thrombolytic catheter placement]
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Hematoma is the subjec t of a report. According to news reporting out of Nanjing, People's Republic of China, by NewsRx editors, research stated, "Spontaneous intracerebral hemorrhage (ICH) accounts for up to 20% of all strokes and results in 40% mortality at 30 days. Although conservative medical management is still the stan dard treatment for ICH patients with small hematoma, patients with residual hema toma 15 mL after surgery are associated with better functional outcomes and surv ival rates." Our news journalists obtained a quote from the research from the Nanjing Univers ity of Chinese Medicine, "This study reported our clinical experience with using Robotic Stereotactic Assistance (ROSA) as a safe and effective approach for ste reotactic ICH aspiration and intra-clot catheter placement. A retrospective anal ysis was conducted of patients with spontaneous ICH who underwent ROSA-guided IC H aspiration surgery. ROSA-guided ICH surgical techniques, an aspiration and int ra-clot catheter placement protocol, and a specific operative workflow (pre-oper ative protocol, intraoperative procedure and postoperative management) were empl oyed to aspirate ICH using the ROSA One Brain, and appropriate follow-up care wa s provided. From September 14, 2021 to May 4, 2022, a total of 7 patients were i ncluded in the study. Based on our workflow design, ROSA-guided stereotactic ICH aspiration effectively aspirated more than 50% of hematoma volume (or more than 30 mL for massive hematomas), thereby reducing the residual hemat oma to less than 15 mL. The mean operative time of entire surgical procedure was 1.3 ± 0.3 h, with very little perioperative blood loss and no perioperative com plications. No patients required catheter replacement and all patients' function al status improved."
NanjingPeople's Republic of ChinaAsi aAngiologyEmerging TechnologiesHealth and MedicineHematomaMachine Lear ningRoboticsRobotsThrombolytics
NETL
NSTL
